These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 29148418)
1. Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation. Guzelant G; Ucar D; Esatoglu SN; Hatemi G; Ozyazgan Y; Yurdakul S; Seyahi E; Yazici H; Hamuryudan V Clin Exp Rheumatol; 2017; 35 Suppl 108(6):86-89. PubMed ID: 29148418 [TBL] [Abstract][Full Text] [Related]
2. A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet's syndrome. Horiguchi N; Kamoi K; Horie S; Iwasaki Y; Kurozumi-Karube H; Takase H; Ohno-Matsui K Sci Rep; 2020 Dec; 10(1):22227. PubMed ID: 33335139 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of infliximab in patients with Behçet's disease-associated uveitis. Yamana S; Hasegawa E; Takeda A; Yawata N; Sonoda KH Int Ophthalmol; 2023 Mar; 43(3):937-944. PubMed ID: 36057758 [TBL] [Abstract][Full Text] [Related]
4. The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study. Santos-Gómez M; Calvo-Río V; Blanco R; Beltrán E; Mesquida M; Adán A; Cordero-Coma M; García-Aparicio ÁM; Valls Pascual E; Martínez-Costa L; Hernández MV; Hernandez Garfella M; González-Vela MC; Pina T; Palmou-Fontana N; Loricera J; Hernández JL; González-Gay MA Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S34-S40. PubMed ID: 27054359 [TBL] [Abstract][Full Text] [Related]
5. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases. Atienza-Mateo B; Martín-Varillas JL; Calvo-Río V; Demetrio-Pablo R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adan A; Hernández MV; Hernández-Garfella M; Valls-Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero-Coma M; Díaz-Llopis M; Gallego R; García-Serrano JL; Ortego-Centeno N; Herreras JM; Fonollosa A; Garcia-Aparicio ÁM; Maíz-Alonso O; Blanco A; Torre-Salaberri I; Fernandez-Espartero C; Jovaní V; Peiteado D; Pato E; Cruz J; Férnandez-Cid C; Aurrecoechea E; García-Arias M; Castañeda S; Caracuel-Ruiz MA; Montilla-Morales CA; Atanes-Sandoval A; Francisco F; Insua S; González-Suárez S; Sanchez-Andrade A; Gamero F; Linares Ferrando LF; Romero-Bueno F; García-González AJ; González RA; Muro EM; Carrasco-Cubero C; Olive A; Prior Á; Vázquez J; Ruiz-Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernandez S; Fernández-Carballido C; Rubio-Romero E; Pages FA; Toyos-Sáenz de Miera FJ; Martinez MG; Díaz-Valle D; López Longo FJ; Nolla JM; Álvarez ER; Martínez MR; González-López JJ; Rodríguez-Cundin P; Hernández JL; González-Gay MA; Blanco R Arthritis Rheumatol; 2019 Dec; 71(12):2081-2089. PubMed ID: 31237427 [TBL] [Abstract][Full Text] [Related]
7. Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis. Fabiani C; Sota J; Vitale A; Emmi G; Vannozzi L; Bacherini D; Lopalco G; Guerriero S; Venerito V; Orlando I; Franceschini R; Fusco F; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L Ocul Immunol Inflamm; 2019; 27(1):34-39. PubMed ID: 29099660 [TBL] [Abstract][Full Text] [Related]
8. Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 Patients. Kunimi K; Usui Y; Asakage M; Maehara C; Tsubota K; Mitsuhashi R; Umazume A; Kezuka T; Sakai JI; Goto H Ocul Immunol Inflamm; 2022 Jan; 30(1):223-230. PubMed ID: 32815752 [TBL] [Abstract][Full Text] [Related]
9. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients. Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907 [TBL] [Abstract][Full Text] [Related]
10. Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy. Yoshida A; Kaburaki T; Okinaga K; Takamoto M; Kawashima H; Fujino Y Jpn J Ophthalmol; 2012 Nov; 56(6):536-43. PubMed ID: 23053631 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behçet's disease. Keino H; Watanabe T; Nakayama M; Komagata Y; Fukuoka K; Okada AA Br J Ophthalmol; 2021 Nov; 105(11):1525-1533. PubMed ID: 32972915 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study. Takeuchi M; Kezuka T; Sugita S; Keino H; Namba K; Kaburaki T; Maruyama K; Nakai K; Hijioka K; Shibuya E; Komae K; Hori J; Ohguro N; Sonoda KH; Mizuki N; Okada AA; Ishibashi T; Goto H; Mochizuki M Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593 [TBL] [Abstract][Full Text] [Related]
13. Biosimilar infliximab for Behçet's syndrome: a case series. Dincses E; Esatoglu SN; Ozguler Y; Uygunoglu U; Hamuryudan V; Seyahi E; Melikoglu M; Fresko I; Ucar D; Ozyazgan Y; Kutlubay Z; Mat MC; Yurdakul S; Siva A; Hatemi G Clin Exp Rheumatol; 2019; 37 Suppl 121(6):111-115. PubMed ID: 31856937 [TBL] [Abstract][Full Text] [Related]
14. An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet's disease in long-term remission. Ida Y; Takeuchi M; Ishihara M; Shibuya E; Yamane T; Hasumi Y; Kawano S; Kimura I; Mizuki N Jpn J Ophthalmol; 2021 Nov; 65(6):843-848. PubMed ID: 34586526 [TBL] [Abstract][Full Text] [Related]
15. Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab. Ucan Gunduz G; Yalcinbayir O; Cekic S; Yildiz M; Kilic SS J Ocul Pharmacol Ther; 2021 May; 37(4):236-240. PubMed ID: 33512278 [No Abstract] [Full Text] [Related]
16. Cataract surgery under infliximab therapy in a patient with Behçet's disease. Noda E; Yamanishi S; Shiraishi A; Ohashi Y J Ocul Pharmacol Ther; 2009 Oct; 25(5):467-70. PubMed ID: 19857109 [TBL] [Abstract][Full Text] [Related]
17. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study. Interlandi E; Leccese P; Olivieri I; Latanza L Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224 [TBL] [Abstract][Full Text] [Related]
18. Predictors of infliximab refractory intestinal Behçet's syndrome: A retrospective cohort study from the Shanghai Behçet's syndrome database. Bao HF; Hou CC; Ye B; Zou J; Luo D; Cai JF; Shen Y; Guan JL Mod Rheumatol; 2023 Jan; 33(1):207-216. PubMed ID: 34932796 [TBL] [Abstract][Full Text] [Related]
19. Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis. Kurata I; Tsuboi H; Takahashi H; Abe S; Ebe H; Hagiwara S; Umeda N; Kondo Y; Ogishima H; Suzuki T; Matsumoto I; Hoshi S; Oshika T; Sumida T Intern Med; 2015; 54(12):1553-7. PubMed ID: 26073249 [TBL] [Abstract][Full Text] [Related]
20. Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network. Vallet H; Seve P; Biard L; Baptiste Fraison J; Bielefeld P; Perard L; Bienvenu B; Abad S; Rigolet A; Deroux A; Sene D; Perlat A; Marie I; Feurer E; Hachulla E; Fain O; Clavel G; Riviere S; Bouche PA; Gueudry J; Pugnet G; Le Hoang P; Resche Rigon M; Cacoub P; Bodaghi B; Saadoun D; Arthritis Rheumatol; 2016 Jun; 68(6):1522-30. PubMed ID: 27015607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]